Does an endogenous methylpyridinium analogue cause Parkinson's disease?

MLA

Brenda Costall, et al. “Does an Endogenous Methylpyridinium Analogue Cause Parkinson’s Disease?” Journal of Pharmacy and Pharmacology, vol. 37, Sept. 1985, pp. 679–80. EBSCOhost, https://doi.org/10.1111/j.2042-7158.1985.tb05116.x.

APA

Brenda Costall, C. D. Marsden, Peter Jenner, R. Naylor, & Bernard Testa. (1985). Does an endogenous methylpyridinium analogue cause Parkinson’s disease? Journal of Pharmacy and Pharmacology, 37, 679–680. https://doi.org/10.1111/j.2042-7158.1985.tb05116.x

Chicago

Brenda Costall, C. D. Marsden, Peter Jenner, R. Naylor, and Bernard Testa. 1985. “Does an Endogenous Methylpyridinium Analogue Cause Parkinson’s Disease?” Journal of Pharmacy and Pharmacology 37 (September): 679–80. doi:10.1111/j.2042-7158.1985.tb05116.x.